PET is necessary to make the next step forward in understanding MS pathophysiology

Abstract

Get full access to this article

View all access options for this article.

References

Benavides

Cornu

Dennis

et al . Imaging of human brain lesions with an omega 3 site radioligand. Ann Neurol 1988; 24(6): 708–712.

Bodini

Stankoff

. PET is necessary to make the next step forward in understanding MS pathophysiology–Yes. Mult Scler 2019; 25: 1086–1087.

DiFilippo

Portaccio

Mancini

et al . Multiple sclerosis and cognition: Synaptic failure and network dysfunction. Nat Rev Neurosci 2018; 19(10): 599–609.

Preziosa

Rocca

Filippi

. PET is necessary to make the next step forward in understanding MS pathophysiology–No. Mult Scler 2019; 25: 1088–1090.

Ikawa

Lohith

Shrestha

et al . 11C-ER176, a Radioligand for 18-kDa translocator protein, has adequate sensitivity to robustly image all three affinity genotypes in human brain. J Nucl Med 2017; 58(2): 320–325.

Hogel

Rissanen

Vuorimaa

et al . Positron emission tomography imaging in evaluation of MS pathology in vivo. Mult Scler 2018; 24(11): 1399–1412.

Kang

Schlyer

Kaunzner

et al . Comparison of two different methods of image analysis for the assessment of microglial activation in patients with multiple sclerosis using (R)-[N-methyl-carbon-11]PK11195. PLoS One 2018; 13(8): e0201289.

Rizzo

Veronese

Tonietto

et al . Generalization of endothelial modelling of TSPO PET imaging: Considerations on tracer affinities. J Cereb Blood Flow Metab. Epub ahead of print 1 January 2017. DOI: 10.1177/0271678X17742004.

PET is necessary to make the next step forward in understanding MS pathophysiology – Commentary

Abstract

Get full access to this article

References